Bruker Corp
BRKR
Market Cap$5.69B
Close$
$58.61
51.3% upside
Current Fair Value
51.3% upsideUndervalued by 51.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.69 Billion |
|---|---|
| Enterprise Value | $8.04 Billion |
| Dividend Yield | $0.2 (0.533049040511727%) |
| Earnings per Share | $0.76 |
| Beta | 1.23 |
| Outstanding Shares | 151,600,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 50.29 |
|---|---|
| PEG | -53.88 |
| Price to Sales | 1.76 |
| Price to Book Ratio | 3.52 |
| Enterprise Value to Revenue | 2.39 |
| Enterprise Value to EBIT | 39.83 |
| Enterprise Value to Net Income | 71 |
| Total Debt to Enterprise | 0.32 |
| Debt to Equity | 1.41 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bruker Corp
6,000 employees
CEO: Frank Laukien Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...